Historique
Article de Périodique
Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs (2020)
Auteur(s) :
V. CARRIERI ;
L. MADIO ;
F. PRINCIPE
Article en page(s) :
art. 102371
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
MAR (Marchés / Markets)
Thésaurus géographique
ITALIE
Thésaurus mots-clés
CANNABIS
;
AUTOMEDICATION
;
USAGE THERAPEUTIQUE
;
MEDICAMENTS
;
CANNABINOIDES
;
LIBERALISATION
;
MARCHE DE LA DROGUE
;
PRODUIT DE SUBSTITUTION
Résumé :
Governments worldwide are increasingly concerned about the booming use of CBD (cannabidiol) products. However, we know little about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using unique and high-frequency data on prescription drug sales and by exploiting the staggered local availability of the new product in each Italian province, we document a significant substitution effect between light cannabis and anxiolytics, sedatives, opioids, anti-depressants and anti-psychotics. Results are informative for regulators and suggest that bans on light cannabis use would disregard the needs of patients to seek effective reliefs of their symptoms.
Affiliation :
Department of Law, Economics and Sociology, "Magna Graecia" University, Catanzaro, Italy